Given that the expression of PD-1 on TILs has been established to be associated with prognosis in HCC, we sought to assess the utility of peripheral lymphocyte cells, including PD-1+ T cells, as biomarkers for predicting disease progression and prognosis in patients with HCC. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.